Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy
Go back to Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 89.60 -0.09 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.69 | 52 Week High | $96.38 | |||
| Open | $89.73 | 52 Week Low | $47.92 | |||
| Day High | $91.00 | P/E | N/A | |||
| Day Low | $89.05 | EPS | $-0.42 | |||
| Volume | 500,420 | |||||
| Insulet Corporation (NASDAQ: PODD) | Delayed: 149.41 +1.27 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.14 | 52 Week High | $45.60 | |||
| Open | $148.14 | 52 Week Low | $23.94 | |||
| Day High | $149.66 | P/E | N/A | |||
| Day Low | $145.16 | EPS | $-1.00 | |||
| Volume | 522,365 | |||||
